PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 28, 2024Expert Opinion on Emerging Drugs3 citationsOpen Access

Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver

View Full Paper
SCSimone Di ColaSKSaniya KhanLLLucia Lapenna

Key Points

Key points are not available for this paper at this time.

Abstract

Malnutrition and sarcopenia are common and impact the prognosis in patients with liver cirrhosis. The etiology is multifactorial and includes periods of reduced caloric intake, increased catabolism and direct molecular mechanisms that inhibit muscle synthesis. Although these conditions are widely acknowledged, and there is a growing interest in their diagnosis, robust evidence regarding the treatment and reversibility of these conditions is still lacking.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cola et al. (2024) studied this question.

synapsesocial.com/papers/68e71edfb6db643587698c9bhttps://doi.org/10.1080/14728214.2024.2332428
Ask AI
Helpful
Bookmark
Share
View Full Paper